Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × tempol × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ototoxicity 1 Mucositis 1

Interventions

semaglutide 3 naldemedine 3 Specimen Handling 3 Metformin 3 Interviews as Topic 3 Tirzepatide 2 Tablets 2 Standard of Care 2 Paclitaxel 2 Observation 2 Methods 2 Exercise 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 Cisplatin 2 Carboplatin 2 Caloric Restriction 2 trametinib 1 tempol 1 sotorasib 1 selpercatinib 1 polyethylene glycol 3350 1 pembrolizumab 1 osimertinib 1 naloxegol 1 mirabegron 1 maltodextrin 1 lorlatinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡